Current Drug Targets
Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Drug Targets, Volume 13 - Number 6
Editorial [Hot Topic: Pancreatic Cancer: Between Bench and Bedside (Guest Editors: Davide Melisi and Alfredo Budillon)]
, 13(6): 729 - 730Davide Melisi and Alfredo Budillon
DOI: 10.2174/138945012800564130
Molecular and Genetic Bases of Pancreatic Cancer
, 13(6): 731 - 743Vanja Vaccaro, Alain Gelibter, Emilio Bria, Pierluigi Iapicca, Paola Cappello, Francesca Di Modugno, Maria Simona Pino, Carmen Nuzzo, Francesco Cognetti, Francesco Novelli, Paola Nistico and Michele Milella
DOI: 10.2174/138945012800564077
Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside Translation
, 13(6): 744 - 752Vincenzo Corbo, Giampaolo Tortora and Aldo Scarpa
DOI: 10.2174/138945012800564103
Is Preoperative Endoscopic Biliary Drainage Indicated for Jaundiced Patients with Resectable Pancreatic Cancer?
, 13(6): 753 - 763Mario de Bellis, Raffaele Palaia, Claudia Sandomenico, Elena Di Girolamo, Marco Cascella and Francesco Fiore
DOI: 10.2174/138945012800564167
Pancreatic Cancer Surgery: The State of the Art
, 13(6): 764 - 771Song Cheol Kim, Young Hoon Kim, Kwang Min Park and Young Ju Lee
DOI: 10.2174/138945012800564185
Vascular Resection in Pancreaticoduodenectomy: Is it Worthwhile?
, 13(6): 772 - 780Francesco Bianco, Cinzia Sassaroli, Paolo Delrio, Silvia De Franciscis and Giovanni Romano
DOI: 10.2174/138945012800564121
Conventional Chemotherapy of Advanced Pancreatic Cancer
, 13(6): 795 - 801Francesco Giuliani, Massimo Di Maio, Giuseppe Colucci and Francesco Perrone
DOI: 10.2174/138945012800564149
Targeting EGFR in Pancreatic Cancer Treatment
, 13(6): 802 - 810T. Troiani, E. Martinelli, A. Capasso, F. Morgillo, Michele Orditura, F. De Vita and F. Ciardiello
DOI: 10.2174/138945012800564158
Systemic Therapies for Pancreatic Cancer - The Role of Pharmacogenetics
, 13(6): 811 - 828Ross A. Soo, Wei-Peng Yong and Federico Innocenti
DOI: 10.2174/138945012800564068
To Cardiovascular Disease and Beyond: New Therapeutic Perspectives of Statins in Autoimmune Diseases and Cancer
, 13(6): 829 - 841Chary Lopez-Pedrera, Patricia Ruiz-Limon, Araceli Valverde-Estepa, Nuria Barbarroja and Antonio Rodriguez-Ariza
DOI: 10.2174/138945012800564112
Adenosine Deaminase in the Modulation of Immune System and its Potential as a Novel Target for Treatment of Inflammatory Disorders
, 13(6): 842 - 862Luca Antonioli, Rocchina Colucci, Concettina La Motta, Marco Tuccori, Oriana Awwad, Federico Da Settimo, Corrado Blandizzi and Matteo Fornai
DOI: 10.2174/138945012800564095
Apixaban: A New Player in the Anticoagulant Class
, 13(6): 863 - 875Ritesh Agrawal, Pratima Jain and S. N. Dikshit
DOI: 10.2174/138945012800564059
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63
Webmaster Contact: info@benthamscience.net